1
|
Paul P, Kaushik B, Kumar A, Sharma P, Rajput D, Chowdhury N. Malignant pleural effusion from a case of squamous-cell carcinoma of the oral cavity: Cytological detection of a rare outcome. Diagn Cytopathol 2023; 51:E161-E163. [PMID: 36718831 DOI: 10.1002/dc.25110] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/31/2022] [Revised: 01/17/2023] [Accepted: 01/18/2023] [Indexed: 02/01/2023]
Abstract
Distant metastases from carcinomas of the oral cavity are rare. Detection of these metastasis are essential for staging and management of the patient. These tumours may metastasize to lung, liver, brain and bone; but pleural involvement by squamous-cell carcinoma is distinctly rare. We present a case of bilateral pleural effusion arising from distant metastasis of squamous-cell carcinoma detected on cytology.
Collapse
Affiliation(s)
- Pranoy Paul
- Department of Pathology and Laboratory Medicine, All India Institute of Medical Sciences, Rishikesh, India
| | - Bhoomika Kaushik
- Department of Pathology and Laboratory Medicine, All India Institute of Medical Sciences, Rishikesh, India
| | - Arvind Kumar
- Department of Pathology and Laboratory Medicine, All India Institute of Medical Sciences, Rishikesh, India
| | - Prakhar Sharma
- Department of Pulmonary Medicine, All India Institute of Medical Sciences, Rishikesh, India
| | - Deepak Rajput
- Department of General Surgery, All India Institute of Medical Sciences, Rishikesh, India
| | - Nilotpal Chowdhury
- Department of Pathology and Laboratory Medicine, All India Institute of Medical Sciences, Rishikesh, India
| |
Collapse
|
2
|
Smetanina SV, Uskova EYU, Khusiyanova AA, Danyaeva MB, Korol'kova SB, Slavnova EN, Voronova NN. Cellular composition research of serous pleural effusion fluids. Conceptual issues of preanalytics. Klin Lab Diagn 2021; 66:95-98. [PMID: 33734642 DOI: 10.51620/0869-2084-2021-66-2-95-98] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022]
Abstract
The purpose of this work was to show the effectiveness of the cytological method on a small number of observations, excluding all possible errors of the preanalytical stage. The paper presents several simple and easily reproducible algorithms for the cytological study of serous pleural effusions with small cellular content. On the example of 20 observations of the study of the cellular composition of serous exudates, a direct dependence of the research results on the preanalytical stage is shown. A complete study of effusion fluids in compliance with all stages of preanalytics and the use of modern methods of cytological diagnostics makes it possible to nullify the options for false-negative.
Collapse
Affiliation(s)
| | - E Y U Uskova
- Nizhny Novgorod Regional Clinical Oncology Center
| | | | - M B Danyaeva
- Nizhny Novgorod Regional Clinical Oncology Center
| | | | - E N Slavnova
- Moscow Research Oncological Institute named after P.A. Herzen - branch of the Federal State Budgetary Institution "National Medical Research Center of Radiology" of the Ministry of Health of the Russian Federation
| | - N N Voronova
- FGAOU VO First MGMU named after I.M. Sechenov of the Ministry of Health of the Russian Federation (Sechenov University)
| |
Collapse
|
3
|
Bibby AC, Dorn P, Psallidas I, Porcel JM, Janssen J, Froudarakis M, Subotic D, Astoul P, Licht P, Schmid R, Scherpereel A, Rahman NM, Maskell NA, Cardillo G. ERS/EACTS statement on the management of malignant pleural effusions. Eur J Cardiothorac Surg 2019; 55:116-132. [PMID: 30060030 DOI: 10.1093/ejcts/ezy258] [Citation(s) in RCA: 44] [Impact Index Per Article: 8.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 02/18/2018] [Accepted: 03/28/2018] [Indexed: 12/26/2022] Open
Abstract
Malignant pleural effusions (MPE) are a common pathology, treated by respiratory physicians and thoracic surgeons alike. In recent years, several well-designed randomized clinical trials have been published that have changed the landscape of MPE management. The European Respiratory Society (ERS) and the European Association for Cardio-Thoracic Surgery (EACTS) established a multidisciplinary collaboration of clinicians with expertise in the management of MPE with the aim of producing a comprehensive review of the scientific literature. Six areas of interest were identified, including the optimum management of symptomatic MPE, management of trapped lung in MPE, management of loculated MPE, prognostic factors in MPE, whether there is a role for oncological therapies prior to intervention for MPE and whether a histological diagnosis is always required in MPE. The literature revealed that talc pleurodesis and indwelling pleural catheters effectively manage the symptoms of MPE. There was limited evidence regarding the management of trapped lung or loculated MPE. The LENT score was identified as a validated tool for predicting survival in MPE, with Brims' prognostic score demonstrating utility in mesothelioma prognostication. There was no evidence to support the use of oncological therapies as an alternative to MPE drainage, and the literature supported the use of tissue biopsy as the gold standard for diagnosis and treatment planning.Management options for malignant pleural effusions have advanced over the past decade, with high-quality randomized trial evidence informing practice in many areas. However, uncertainties remain and further research is required http://ow.ly/rNt730jOxOS.
Collapse
Affiliation(s)
- Anna C Bibby
- Academic Respiratory Unit, University of Bristol Medical School Translational Health Sciences, Bristol, UK
- North Bristol Lung Centre, North Bristol NHS Trust, Bristol, UK
| | - Patrick Dorn
- Division of Thoracic Surgery, University Hospital Bern, Bern, Switzerland
| | | | - Jose M Porcel
- Pleural Medicine Unit, Arnau de Vilanova University Hospital, IRB Lleida, Lleida, Spain
| | - Julius Janssen
- Department of Pulmonary Diseases, Canisius Wilhelmina Hospital, Nijmegen, The Netherlands
| | - Marios Froudarakis
- Department of Respiratory Medicine, Medical School of Alexandroupolis, Democritus University of Thrace, Alexandroupolis, Greece
| | - Dragan Subotic
- Clinic for Thoracic Surgery, Clinical Center of Serbia, Belgrade, Serbia
| | - Phillippe Astoul
- Department of Thoracic Oncology, Pleural Diseases and Interventional Pulmonology, Hospital North Aix-Marseille University, Marseille, France
| | - Peter Licht
- Department of Cardiothoracic Surgery, Odense University Hospital, Odense, Denmark
| | - Ralph Schmid
- Division of Thoracic Surgery, University Hospital Bern, Bern, Switzerland
| | - Arnaud Scherpereel
- Pulmonary and Thoracic Oncology Department, Hospital of the University (CHU) of Lille, Lille, France
| | - Najib M Rahman
- Oxford Respiratory Trials Unit, University of Oxford, Oxford, UK
- Oxford Centre for Respiratory Medicine, University Hospitals, NHS Foundation Trust, Oxford, UK
| | - Nick A Maskell
- Academic Respiratory Unit, University of Bristol Medical School Translational Health Sciences, Bristol, UK
- North Bristol Lung Centre, North Bristol NHS Trust, Bristol, UK
- Task force chairperson
| | - Giuseppe Cardillo
- Task force chairperson
- Department of Thoracic Surgery, Carlo Forlanini Hospital, Azienda Ospedaliera San Camillo Forlanini, Rome, Italy
| |
Collapse
|
4
|
Bibby AC, Dorn P, Psallidas I, Porcel JM, Janssen J, Froudarakis M, Subotic D, Astoul P, Licht P, Schmid R, Scherpereel A, Rahman NM, Cardillo G, Maskell NA. ERS/EACTS statement on the management of malignant pleural effusions. Eur Respir J 2018; 52:13993003.00349-2018. [DOI: 10.1183/13993003.00349-2018] [Citation(s) in RCA: 116] [Impact Index Per Article: 19.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/18/2018] [Accepted: 03/28/2018] [Indexed: 02/07/2023]
Abstract
Malignant pleural effusions (MPE) are a common pathology, treated by respiratory physicians and thoracic surgeons alike. In recent years, several well-designed randomised clinical trials have been published that have changed the landscape of MPE management. The European Respiratory Society (ERS) and the European Association for Cardio-Thoracic Surgery (EACTS) established a multidisciplinary collaboration of clinicians with expertise in the management of MPE with the aim of producing a comprehensive review of the scientific literature.Six areas of interest were identified, including the optimum management of symptomatic MPE, management of trapped lung in MPE, management of loculated MPE, prognostic factors in MPE, whether there is a role for oncological therapies prior to intervention for MPE and whether a histological diagnosis is always required in MPE.The literature revealed that talc pleurodesis and indwelling pleural catheters effectively manage the symptoms of MPE. There was limited evidence regarding the management of trapped lung or loculated MPE. The LENT score was identified as a validated tool for predicting survival in MPE, with Brims' prognostic score demonstrating utility in mesothelioma prognostication. There was no evidence to support the use of oncological therapies as an alternative to MPE drainage, and the literature supported the use of tissue biopsy as the gold standard for diagnosis and treatment planning.
Collapse
|
5
|
Bambara AT, Ouédraogo SM, Maïga S, Sondo KA, Boncoungou/Nikièma K, Ouédraogo G, Koumbem B, Ouédraogo AS, Djibril M, Badoum G, Ouédraogo AR, Ouédraogo M. [Survival of malignant and paramalignant pleural effusions in Ouagadougou]. REVUE DE PNEUMOLOGIE CLINIQUE 2016; 72:346-352. [PMID: 27776946 DOI: 10.1016/j.pneumo.2016.08.001] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 05/21/2016] [Revised: 08/22/2016] [Accepted: 08/27/2016] [Indexed: 06/06/2023]
Abstract
This study aimed to present the survival of patients with malignant and paramalignant pleural effusion (MPE) in a context of resource-limited countries. We retrospectively studied patients received for malignant and paramalignant pleural effusion in three health facilities in Ouagadougou from 1st August 2009 to 30 July 2015. Survival was analyzed according to various characteristics related to patients and disease. Eighty patients with a mean age of 54 years were selected. The sex-ratio was 0.9. Sixteen patients had comorbidities. Pleural effusion was revealing, synchronous and metachronous in respectively 55 %, 26.3 % and 17.5 % of cases. Lung cancer was the most common cause of MPE (27.5 %), followed by breast cancer (18.7 %). The median overall survival was 3 months; it varied between primary cancers: 5 months for primary cancer unknown, 4 months for lung cancers and 2 months for breast cancers. Sex and the presence of comorbidities were independent factors influencing survival of patients. In this study, patient survival length is strongly compromised by inadequacies of medical technical equipment.
Collapse
Affiliation(s)
- A T Bambara
- Unité de formation et de recherche en sciences de la santé, BP 7021, Ouagadougou, Burkina Faso; Service de cancérologie, CHU Yalgado Ouédraogo, Ouagadougou, Burkina Faso.
| | - S M Ouédraogo
- Service de médecine interne, CHU Souro Sanou, Bobo-Dioulasso, Burkina Faso; Institut supérieur des sciences de la santé, Bobo-Dioulasso, Burkina Faso
| | - S Maïga
- Service de pneumophtisiologie, CHU Yalgado Ouédraogo, Ouagadougou, Burkina Faso
| | - K A Sondo
- Unité de formation et de recherche en sciences de la santé, BP 7021, Ouagadougou, Burkina Faso; Service de maladies infectieuses, CHU Yalgado Ouédraogo, Ouagadougou, Burkina Faso
| | - K Boncoungou/Nikièma
- Unité de formation et de recherche en sciences de la santé, BP 7021, Ouagadougou, Burkina Faso; Service de pneumophtisiologie, CHU Yalgado Ouédraogo, Ouagadougou, Burkina Faso
| | - G Ouédraogo
- Unité de formation et de recherche en sciences de la santé, BP 7021, Ouagadougou, Burkina Faso; Service de pneumophtisiologie, CHU Yalgado Ouédraogo, Ouagadougou, Burkina Faso
| | - B Koumbem
- Service de pneumophtisiologie, CHU Yalgado Ouédraogo, Ouagadougou, Burkina Faso
| | - A S Ouédraogo
- Unité de formation et de recherche en sciences de la santé, BP 7021, Ouagadougou, Burkina Faso; Service d'anatomie pathologique, CHU Yalgado Ouédraogo, Ouagadougou, Burkina Faso
| | - M Djibril
- Service de réanimation médicale, CHU Sylvanus Olympio, Lomé, Togo
| | - G Badoum
- Unité de formation et de recherche en sciences de la santé, BP 7021, Ouagadougou, Burkina Faso; Service de pneumophtisiologie, CHU Yalgado Ouédraogo, Ouagadougou, Burkina Faso
| | - A R Ouédraogo
- Unité de formation et de recherche en sciences de la santé, BP 7021, Ouagadougou, Burkina Faso; Service de pneumophtisiologie, CHU Yalgado Ouédraogo, Ouagadougou, Burkina Faso
| | - M Ouédraogo
- Unité de formation et de recherche en sciences de la santé, BP 7021, Ouagadougou, Burkina Faso; Service de pneumophtisiologie, CHU Yalgado Ouédraogo, Ouagadougou, Burkina Faso
| |
Collapse
|
6
|
Sharma M, Sharma A, Thakur P, Fotedar V. Malignant pleural effusions: Differentiating pelvic malignancies. Lung India 2015; 32:677-8. [PMID: 26664198 PMCID: PMC4663895 DOI: 10.4103/0970-2113.168117] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/23/2022] Open
|
7
|
Agrawal A, Tandon R, Singh L, Chawla A. Clinicopathological profile and course of malignant pleural effusion in a tertiary care teaching hospital in western Uttar Pradesh with special reference to lung cancer. Lung India 2015; 32:678-9. [PMID: 26664199 PMCID: PMC4663896 DOI: 10.4103/0970-2113.168122] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/01/2022] Open
|